Subsets of TAMs, such as TREM2+ TAMS, have recently been implicated in promoting an immunosuppressive TME and the simultaneous targeting of these cells in conjunction with aPD1 ICB enhances tumor clearance21,22. This evidence concerns the gene TREM2 and neoplasm.